Pharma Sponsor Enlists Cenduit IRT To Rescue A Multi-Country, Multi-Site Oncology Study
Source: IQVIA Technologies
![Oncology Oncology](https://vertassets.blob.core.windows.net/image/7766943e/7766943e-e245-4b65-93eb-997bc1740d7d/375_250-oncology_pills_450x300.jpg)
The sponsor assessed the safety and tolerability of escalating oral doses of one drug, when combined with the standard dosing of another, in patients with advanced solid malignancies. The client : a global pharmaceutical group focused on developing prescription drugs that target unmet medical needs in numerous indications including oncology.
CHALLENGE: ADAPTIVE DESIGN
- After go-live, the sponsor learned its study did not fit the existing IRT solution, affecting data quality, timelines, and drug supply shipments. Following an RFP, the sponsor asked Cenduit to build a rescue study
- A key factor: the legacy system’s medication management algorithm could not support the required flexibility in the supply chain. The trial included an adaptive cohort design
RESULTS
- Cenduit delivered a high-quality study achieved through innovation, close client collaboration, and expert project management.
access the Case Study!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
IQVIA Technologies
This website uses cookies to ensure you get the best experience on our website. Learn more